Retrospective Analyses of TrakStar Database

Recruiting

• Conditions: Depression; Anxiety Depression; Obsessive-Compulsive Disorder

• Registration Number: NCT06917339
• Lead Sponsor: Neuronetics

Brief Summary

In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.

Detailed Description

Not available

Study Timeline

• Study Start: 2025-02-25
• Status Verified: 2025-03
• Study First Submitted: 2025-03-18
• Study First Submitted QC: 2025-03-31
• Last Update Submitted: 2025-03-31
• Study First Posted: 2025-04-08
• Last Update Posted: 2025-04-08
• Primary Completion: 2035-12
• Study Completion: 2035-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 156000

Inclusion Criteria

• Male or female reported in database and not an invalid entry
• Age reported and not an invalid entry
• Treatment date of November 01, 2008 or later.

Exclusion Criteria

• Incomplete information on treatment parameters

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in clinical assessment score from baseline to post-treatment	8 weeks	real-world efficacy of NeuroStar TMS in reducing patients' symptoms, reduction in clinical assessment score like PHQ-9

Secondary Outcome Measures

Name	Time	Method
Age at baseline and its correlation to change in score post treatment	8 weeks	Determine the patient characteristics like age that are associated with clinical outcomes- PHQ-9 following NeuroStar TMS

Trial Locations

Locations (1)

Neuronetics; 🇺🇸 Malvern, Pennsylvania, United States